Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FUWUS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,302
Award facts
- Contract value 100% obligated
- $21,301.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,301.96 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on November 4, 2025, with completion expected by November 5, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award under AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026. The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania.
This delivery order supports the Defense Health Agency's pharmaceutical supply requirements through AmerisourceBergen's role as a prime vendor in DLA's global pharmaceutical support program. Zepbound is a brand-name glucagon-like peptide-1 (GLP-1) receptor agonist used for weight management and diabetes treatment, reflecting the federal government's procurement of contemporary pharmaceutical therapies for military personnel and beneficiaries. AmerisourceBergen's comprehensive pharmaceutical distribution capabilities, demonstrated through its substantial IDC portfolio and consistent competitive awards from DLA, position the company as a critical supplier of specialty and brand-name medications across multiple therapeutic domains for the military healthcare system.
Quick answers
Who was awarded contract SPE2DB26FUWUS?
SPE2DB26FUWUS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FUWUS worth?
The government has obligated $21,302 on SPE2DB26FUWUS.
Is contract SPE2DB26FUWUS an order under another contract?
Yes. SPE2DB26FUWUS is a delivery order under SPE2DB25D3018, an indefinite delivery contract.
Was contract SPE2DB26FUWUS competed?
The extent of competition for SPE2DB26FUWUS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award